Search

  • HOME
  • Search
Letter to the Editor
Functional cure of chronic hepatitis B encounters resmetirom
Nai-Bin Yang, Wai-Kay Seto, Ming-Hua Zheng
Clin Mol Hepatol. 2024;30(3):580-581.   Published online April 30, 2024
View: 1784   Download: 90
Original Article
1928
Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy
Qi Wang, Qingfa Bu, Zibo Xu, Yuan Liang, Jinren Zhou, Yufeng Pan, Haoming Zhou, Ling Lu
Clin Mol Hepatol. 2024;30(3):515-538.   Published online May 10, 2024
View: 2679   Download: 239
1747
Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
Yi-wen Shi, Jian-Gao Fan
Clin Mol Hepatol. 2023;29(Suppl):S228-S243.   Published online December 14, 2022
View: 4070   Download: 112
1738
Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
Silvia Sookoian, Carlos J. Pirola
Clin Mol Hepatol. 2023;29(Suppl):S184-S195.   Published online December 5, 2022
View: 4403   Download: 190  Web of Science: 11  Crossref: 13
Non-alcoholic fatty liver disease: Definition and subtypes
Seul Ki Han, Soon Koo Baik, Moon Young Kim
Clin Mol Hepatol. 2023;29(suppl):S5-S16.   Published online December 28, 2022
View: 8030   Download: 531  Web of Science: 55  Crossref: 58
Editorial
Adding to the confusion in more than just the name
Jacob George
Clin Mol Hepatol. 2023;29(4):973-976.   Published online September 18, 2023
View: 2011   Download: 74  Web of Science: 6  Crossref: 6
Correspondence
Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
Seul Ki Han, Soon Koo Baik, Moon Young Kim
Clin Mol Hepatol. 2023;29(3):817-819.   Published online May 17, 2023
View: 2255   Download: 48
Original Article
1790
Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis
Min Jeong Park, Hayeon Kim, Myeong Gyu Kim, Kyungim Kim
Clin Mol Hepatol. 2023;29(3):693-704.   Published online March 9, 2023
View: 3751   Download: 185  Web of Science: 8  Crossref: 8
Editorial
Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
Margaret LP Teng, Darren Jun Hao Tan, Cheng Han Ng, Daniel Q. Huang
Clin Mol Hepatol. 2023;29(2):404-407.   Published online March 14, 2023
View: 3194   Download: 81  Web of Science: 2  Crossref: 2
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
Kee-Huat Chuah, Wah-Kheong Chan
Clin Mol Hepatol. 2023;29(2):401-403.   Published online February 28, 2023
View: 3005   Download: 70  Web of Science: 3  Crossref: 3
Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
Ho Soo Chun, Minjong Lee
Clin Mol Hepatol. 2023;29(2):377-380.   Published online March 9, 2023
View: 2927   Download: 102  Web of Science: 2  Crossref: 1
Review
1714
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Kuei-Chuan Lee, Pei-Shan Wu, Han-Chieh Lin
Clin Mol Hepatol. 2023;29(1):77-98.   Published online October 13, 2022
View: 10958   Download: 706  Web of Science: 56  Crossref: 56
Snapshot
1689
Personalized medicine in nonalcoholic fatty liver disease
Carlos J. Pirola, Silvia Sookoian
Clin Mol Hepatol. 2022;28(4):935-938.   Published online June 24, 2022
View: 4759   Download: 147  Web of Science: 7  Crossref: 6
Editorial
1701
Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait
Carlos J. Pirola, Silvia Sookoian
Clin Mol Hepatol. 2022;28(4):806-809.   Published online August 19, 2022
View: 2758   Download: 72
Review
1678
Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen
Clin Mol Hepatol. 2022;28(4):790-801.   Published online May 11, 2022
View: 7789   Download: 510  Web of Science: 46  Crossref: 46
Editorial
A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease
Seonghwan Hwang, Won Kim
Clin Mol Hepatol. 2022;28(3):478-480.   Published online June 16, 2022
View: 3428   Download: 93
Original Article
1597
Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis
Gang Xu, Yu-Min Wang, Miao-Miao Ying, Sui-Dan Chen, Zong-Rui Li, Hong-Lei Ma, Ming-Hua Zheng, Jian Wu, Chunming Ding
Clin Mol Hepatol. 2021;27(2):329-345.   Published online January 20, 2021
View: 7576   Download: 233  Web of Science: 15  Crossref: 16
Special topic: Alcoholic liver diseases
The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)
Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases
Yun Seok Kim, Sang Geon Kim
Clin Mol Hepatol. 2020;26(4):715-727.   Published online September 22, 2020
View: 10076   Download: 279  Web of Science: 33  Crossref: 34
Review
1531
Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
Silvia Sookoian, Carlos J. Pirola
Clin Mol Hepatol. 2020;26(4):461-475.   Published online September 10, 2020
View: 9008   Download: 289  Web of Science: 40  Crossref: 40
Review
Recent research trends and updates on nonalcoholic fatty liver disease
Jeong-Ju Yoo, Won Kim, Moon Young Kim, Dae Won Jun, Sang Gyune Kim, Jong-Eun Yeon, Jin Woo Lee, Yong Kyun Cho, Sang Hoon Park, Joo Hyun Sohn
Clin Mol Hepatol. 2019;25(1):1-11.   Published online August 8, 2018
View: 19312   Download: 721  Web of Science: 70  Crossref: 66
Original Article
1388
Serum matrix metalloproteinase-1 level represents disease activity as opposed to fibrosis in patients with histologically proven nonalcoholic steatohepatitis
Wataru Ando, Hiroaki Yokomori, Nobuhiro Tsutsui, Eigoro Yamanouchi, Yutaka Suzuki, Masaya Oda, Yutaka Inagaki, Katsuya Otori, Isao Okazaki
Clin Mol Hepatol. 2018;24(1):61-76.   Published online November 20, 2017
View: 9780   Download: 178  Web of Science: 30  Crossref: 30
Review
NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
Stephen Caldwell
Clin Mol Hepatol. 2017;23(2):103-108.   Published online May 10, 2017
View: 12814   Download: 482  Web of Science: 33  Crossref: 33
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
The Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol. 2013;19(4):325-348.   Published online December 28, 2013
View: 14108   Download: 164  Crossref: 95
Editorial
Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis
Goh Eun Chung, Donghee Kim
Clin Mol Hepatol. 2013;19(2):116-119.   Published online June 27, 2013
View: 7151   Download: 93
Case Report
Severe steatohepatitis with hepatic decompensation resulting from malnutrition after pancreaticoduodenectomy
Eun Hui Sim, Jung Hyun Kwon, Se Young Kim, Seung Min Jung, Lee-So Maeng, Jeong Won Jang, Kyu Won Chung
Clin Mol Hepatol. 2012;18(4):404-410.   Published online December 21, 2012
View: 7737   Download: 86  Crossref: 16
3
Validity and reliability of the nonalcoholic fatty Liver diseases activity score (NAS) in Korean NAFLD patients and its correlation with clinical factors
Kyung-Hun Lee, M.D., Sang Hoon Park, M.D., Yu Jin Kim, M.D., Kyung Rim Huh, M.D., Kwang Seon Min M.D., Sun-Young Jun M.D., Kyoung Oh Kim, M.D., Cheol Hee Park, M.D., Taeho Hahn, M.D., Kyo-Sang Yoo, M.D., Jong Hyeok Kim, M.D., Myung-Seok Lee, M.D., Choong Kee Park, M.D.
Clin Mol Hepatol. 2010;16(1):29-37.   Published online March 26, 2010
View: 5288   Download: 56  Crossref: 2
Current status of Liver diseases in Korea: nonalcoholic fatty Liver disease
Sang Hoon Park
Clin Mol Hepatol. 2009;15(60):34-39.   Published online December 31, 2009
View: 7342   Download: 45  Crossref: 19
2
Pathology of nonalcoholic steatohepatitis
Yoon Mi Jeen , So Young Jin
Clin Mol Hepatol. 2009;15(2):122-130.   Published online June 30, 2009
View: 5226   Download: 57  Crossref: 3
1 | 2 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1753
TOTAL : 2099269
Close layer